During the past decade, Paris Transplant Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paris Transplant Group" #1 collaborator was "Agence de La Biomédecine" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Australian Organ and Tissue Donation and Transplantation Authority" with 1 trials as a collaborator, "Austrotransplant" with 1 trials as a collaborator and "Autoridade Para Services de Sangue e Transplantacáo" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Paris Transplant Group" are "Allograft Arteriopathy" (1 trials), "COVID-19" (1 trials), "Heart Transplantation" (1 trials), "Kidney Failure" (1 trials) and "Kidney Transplant Failure" (1 trials). Many other conditions were trialed in "Paris Transplant Group" in a lesser frequency.

Most popular intervention types in "Paris Transplant Group" are "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biopsies" (1 trials), "Computer based assessment (iBox)" (1 trials), "Latent class mixed modeling" (1 trials) and "Physician assessement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paris Transplant Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Paris Transplant Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Paris Transplant Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Paris Transplant Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".